This is a preview of subscription content, log in via an institution to check access.
Reference
Moser S, et al. Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease. European Journal of Gastroenterology and Hepatology 30: 291-295, No. 3, Mar 2018. Available from: URL: http://doi.org/10.1097/MEG.0000000000001027 -Austria
Rights and permissions
About this article
Cite this article
Ribavirin. Reactions Weekly 1694, 375 (2018). https://doi.org/10.1007/s40278-018-43776-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43776-z